Analysis of potential biomarkers and modifier genes affecting the clinical course of CLN3 disease.
Lebrun AH, Moll-Khosrawi P, Pohl S, Makrypidi G, Storch S, Kilian D, Streichert T, Otto B, Mole SE, Ullrich K, Cotman S, Kohlschütter A, Braulke T, Schulz A.
Lebrun AH, et al. Among authors: kohlschutter a.
Mol Med. 2011;17(11-12):1253-61. doi: 10.2119/molmed.2010.00241. Epub 2011 Aug 18.
Mol Med. 2011.
PMID: 21863212
Free PMC article.